Is SCYNEXIS INC financially healthy?

SCYNEXIS INC scores 4 out of 7 on the Piotroski F-score. Only 7 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Its Altman Z-score puts it in the distress zone. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.

Who are the largest institutional holders of SCYNEXIS INC?

Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are GEODE CAPITAL MANAGEMENT, LLC (trimming), RENAISSANCE TECHNOLOGIES LLC (trimming), BlackRock, Inc. (trimming). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

SCYNEXIS INC (SCYX)

Nasdaq · Common Stock · Pharmaceutical Preparations

One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.

Financial health

Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

4 / 7

FAILReturn on assets positiveROA -14.6%
FAILOperating cash flow positiveOCF -5M
PASSReturn on assets improving-23.5% → -14.6%
PASSCash flow exceeds earningsOCF -5M vs NI -9M
FAILLong-term debt ratio fallingno debt reported
PASSCurrent ratio improving3.00 → 7.04
FAILNo share dilution49M → 50M shares
FAILGross margin improvingno gross profit reported
PASSAsset turnover improving0.04× → 0.35×

Altman Z-score

-6.46distress

Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.

Cash conversion: 61.4%
Share count change: 2.9%

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2020	$0	−$55.2M	−$49.4M	—	—
FY2021	$13.2M	−$32.9M	−$54.6M	—	26,384,713
FY2022	$5.1M	−$62.8M	—	—	42,613,510
FY2023	$140.1M	$67.0M	—	—	48,390,582
FY2024	$3.7M	−$21.3M	—	—	48,513,073
FY2025

Ownership flow

5 institutions tracked — 0 added, 5 reduced, 1 sold out.

Institutional holders of SCYNEXIS INC and their share-count change
Manager	Kind	Shares	Change	Value
GEODE CAPITAL MANAGEMENT, LLC	Index	82,093	−404,275	$334,169
BlackRock, Inc.	Index	41,522	−290,672	$168,995
RENAISSANCE TECHNOLOGIES LLC	Hedge fund	76,525	−148,115	$311,457
STATE STREET CORP	Index	15,090	−105,640	$61,416

Identity

CIK: 0001178253
LEI: 529900XBHFGMNTU70154
FIGI: BBG002133YW4
SIC: 2834 · Pharmaceutical Preparations
Headquarters: JERSEY CITY, NJ

Ownership

Institutional: 62.1%
Institutions: 46
Insiders: 2.1%

Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.

Questions about SCYNEXIS INC

Is SCYNEXIS INC financially healthy?: SCYNEXIS INC scores 4 out of 7 on the Piotroski F-score. Only 7 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Its Altman Z-score puts it in the distress zone. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of SCYNEXIS INC?: Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are GEODE CAPITAL MANAGEMENT, LLC (trimming), RENAISSANCE TECHNOLOGIES LLC (trimming), BlackRock, Inc. (trimming). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

This page is one panel of the terminal

The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.

Download the terminal See pricing

Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.